Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense

Blood

Volumn 118, Issue 9, 2011, Pages 2589-2598

  Loof, Torsten G ^a   Mörgelin, Matthias ^a   Johansson, Linda ^b   Oehmcke, Sonja ^a   Olin, Anders I ^a   Dickneite, Gerhard ^c   Norrby Teglund, Anna ^b   Theopold, Ulrich ^d   Herwald, Heiko ^a  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c CSL BEHRING GMBH   (Germany)

^d STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13; FIBRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; CROSS LINKING; HUMAN; HUMAN TISSUE; IMMOBILIZATION; INFLAMMATION; INNATE IMMUNITY; MOUSE; NECROTIZING FASCIITIS; NONHUMAN; PRIORITY JOURNAL; SERUM BACTERICIDAL ACTIVITY; SKIN INFECTION; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; TISSUE SECTION; WILD TYPE;

EID: 80052397217     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-02-337568     Document Type: Article

References (37)

1. Page M.J., Di Cera E. Serine peptidases: Classification, structure and function. Cell Mol Life Sci. 2008;65(7-8):1220-1236.
2. Davidson C.J., Tuddenham E.G., McVey J.H. 450 million years of hemostasis. J Thromb Haemost. 2003;1(7):1487-1494.
3. Nonaka M., Kimura A. Genomic view of the evolution of the complement system. Immunogenetics. 2006;58(9):701-713. (Pubitemid 44343144)
4. Krem M.M., Di Cera E. Evolution of enzyme cascades from embryonic development to blood coagulation. Trends Biochem Sci. 2002;27(2):67-74. (Pubitemid 34164321)
5. Loof T.G., Schmidt O., Herwald H., Theopold U. Coagulation systems of invertebrates and vertebrates and their roles in innate immunity: The same side of two coins? J Innate Immun. 2011;3(1):34-40.
6. Krem M.M., Di Cera E. Molecular markers of serine protease evolution. EMBO J. 2001;20(12):3036-3045. (Pubitemid 32611991)
7. Delvaeye M., Conway E.M. Coagulation and innate immune responses: Can we view them separately? Blood. 2009;114(12):2367-2374.
8. Doolittle R.F. Coagulation in vertebrates with a focus on evolution and inflammation. J Innate Immun. 2011;3(1):9-16.
9. Wang Z., Wilhelmsson C., Hyrsl P., et al. Pathogen entrapment by transglutaminase-a conserved early innate immune mechanism. PLoS Pathog. 2010;6(2):e1000763.
10. Carapetis J.R., Steer A.C., Mulholland E.K.,Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5(11):685-694. (Pubitemid 41505357)
11. Cunningham M.W. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 2000;13(3):470-511. (Pubitemid 30452618)
12. Oehmcke S., Shannon O., Von Köckritz-Blickwede M., et al. Treatment of invasive streptococcal infection with a peptide derived from human high-molecular weight kininogen. Blood. 2009;114(2):444-451.
13. Rasmussen M., Müller H.P., Björck L. Protein GRAB of streptococcus pyogenes regulates proteolysis at the bacterial surface by binding alpha2-macroglobulin. J Biol Chem. 1999;274(22):15336-15344.
14. Herwald H., Mörgelin M., Dahlbäck B., Björck L. Interactions between surface proteins of Streptococcus pyogenes and coagulation factors modulate clotting of human plasma. J Thromb Haemost. 2003;1(2):284-291.
15. Bengtson S.H., Sandén C., Mörgelin M., et al. Activation of TAFI on the surface of Streptococcus pyogenes evokes inflammatory reactions by modulating the kallikrein/kinin system. J Innate Immun. 2008;1(1):18-28.
16. Toppel A.W., Rasmussen M., Rohde M., Medina E., Chhatwal G.S. Contribution of protein G-related alpha2-macroglobulin-binding protein to bacterial virulence in a mouse skin model of group A streptococcal infection. J Infect Dis. 2003;187(11):1694-1703. (Pubitemid 36667879)
17. Malmström E., Mörgelin M., Malmsten M., et al. Protein C inhibitor - A novel antimicrobial agent. PLoS Pathog. 2009;5(12):e1000698.
18. Thulin P., Johansson L., Low D.E., et al. Viable group A streptococci in macrophages during acute soft tissue infection. PLoS Med. 2006;3(3):e53.
19. Hoffman M., Monroe D.M. 3rd. A cell-based model of hemostasis. Thromb Haemost. 2001;85(6):958-965. (Pubitemid 32573743)
20. el Alaoui S., Legastelois S., Roch A.M., Chantepie J., Quash G. Transglutaminase activity and N epsilon (gamma glutamyl) lysine isopeptide levels during cell growth: An enzymic and immunological study. Int J Cancer. 1991;48(2):221-226.
21. Frick I.M., Akesson P., Herwald H., et al. The contact system - A novel branch of innate immunity generating antibacterial peptides. EMBO J. 2006;25(23):5569-5578. (Pubitemid 44847197)
22. Akesson P., Schmidt K.H., Cooney J., Björck L. M1 protein and protein H: IgGFc- and albumin-binding streptococcal surface proteins encoded by adjacent genes. Biochem J. 1994;300(pt 3):877-886. (Pubitemid 24180607)
23. Lauer P., Metzner H.J., Zettlmeissl G., et al. Targeted inactivation of the mouse locus encoding coagulation factor XIII-A: Hemostatic abnormalities in mutant mice and characterization of the coagulation deficit. Thromb Haemost. 2002;88(6):967-974. (Pubitemid 36024124)
24. Eisen D.P. Mannose-binding lectin deficiency and respiratory tract infection. J Innate Immun. 2010;2(2):114-122.
25. Dharmani P., Srivastava V., Kissoon-Singh V., Chadee K. Role of intestinal mucins in innate host defense mechanisms against pathogens. J Innate Immun. 2009;1(2):123-135.
26. Frick I.M., Björck L., Herwald H. The dual role of the contact system in bacterial infectious disease. Thromb Haemost. 2007;98(3):497-502. (Pubitemid 47412875)
27. Rapala-Kozik M., Karkowska J., Jacher A., et al. Kininogen adsorption to the cell surface of Candida spp. Int Immunopharmacol. 2008;8(2):237-241.
28. Gershom E.S., Sutherland M.R., Lollar P., Pryzdial E.L. Involvement of the contact phase and intrinsic pathway in herpes simplex virus-initiated plasma coagulation. J Thromb Haemost. 2010;8(5):1037-1043.
29. Opal S.M., Esmon C.T. Bench-to-bedside review: Functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit Care. 2003;7(1):23-38. (Pubitemid 36204267)
30. Nordahl E.A., Rydengård V., Mörgelin M., Schmidtchen A. Domain 5 of high molecular weight kininogen is antibacterial. J Biol Chem. 2005;280(41):34832-34839. (Pubitemid 41504617)
31. Leeb-Lundberg L.M.F., Marceau F., Müller-Esterl W., Pettibone D.J., Zuraw B.L. International union of pharmacology. XLV. Classification of the kinin receptor family: From molecular mechanisms to pathophysiological consequences. Pharmacol Rev. 2005;57(1):27-77. (Pubitemid 40283969)
32. Papareddy P., Rydengard V., Pasupuleti M., et al. Proteolysis of human thrombin generates novel host defense peptides. PLoS Pathog. 2010;6(4):e1000857.
33. Sun H., Wang X., Degen J.L., Ginsburg D. Reduced thrombin generation increases host susceptibility to group A streptococcal infection. Blood. 2009;113(6):1358-1364.
34. Tapper H., Herwald H. Modulation of hemostatic mechanisms in bacterial infectious diseases. Blood. 2000;96(7):2329-2337.
35. Sodeinde O.A., Subrahmanyam Y.V., Stark K., Quan T., Bao Y., Goguen J.D. A surface protease and the invasive character of plague. Science. 1992;258(5084):1004-1007.
36. Endo Y., Nakazawa N., Iwaki D., Takahashi M., Matsushita M., Fujita T. Interactions of ficolin and mannose-binding lectin with fibrinogen/fibrin augment the lectin complement pathway. J Innate Immun. 2009;2(1):33-42.
37. Bidla G., Hauling T., Dushay M.S., Theopold U. Activation of insect phenoloxidase after injury: Endogenous versus foreign elicitors. J Innate Immun. 2009;1(4):301-308.